News

Novo Nordisk Places Bet on CEO Shake-Up to Reclaim Edge in Weight Loss Drug Race
As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...
Weight-loss company Noom pivots to smaller doses of compounded Wegovy
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Long Island patients lost vision after taking weight loss drugs Ozempic and Wegovy, lawyer contends
The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...
Long Island patients lost vision after taking weight loss drugs Ozempic and Wegovy, lawsuits contend
The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...
STAT18h
Pharmalittle: We’re reading about FDA eyeing PDUFA changes, compounded weight loss drugs, and more
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
Lawsuits are piling up as weight-loss drug users report losing their sight: ‘I definitely wouldn’t have taken it’
More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications ...
Fierce Pharma18h
As Eli Lilly outperforms Novo in market, it also replaces its rival in annual IDEA Innovation rankings
As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have they changed positions in the annual IDEA Pharma Innovation Index, which ...
Barron's19h
Novo Nordisk A/S ADR
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...